Trial Profile
Phase I, Open-label, Randomized, Single-dose, Two Treatment (Fed Versus Fasted) Crossover Study to Assess the Effects of Food on the Pharmacokinetics of TC-5214 (S-Mecamylamine) in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2012
Price :
$35
*
At a glance
- Drugs Dexmecamylamine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 10 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 10 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.